Clinical Trial Update: A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating XW003 in obese adults with obstructive sleep apnea who are on positive airway pressure therapy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea

Drugs mentioned

• XW003

Snippet

Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. | Conditions: OSA - Obstructive Sleep Apnea, Obesity | Phase 3 | Status: RECRUITING